Recent Updates
Recently added Catalysts
HBIO Positive Sentiment Score: 65/100

Harvard Bioscience, Inc. to Participate in Two Investor Conferences in March 2025

Wednesday, March 12, 2025 2 min read
Key Takeaway: Harvard Bioscience, Inc. announced its participation in two investor conferences scheduled for March 2025. The first is the 37th Annual Roth Conference from March 16-18, where management will hold one-on-one meetings and a Fireside Chat. The second event is the KeyBanc Capital Markets Healthcare Forum on March 19, featuring similar engagement opportunities. The participation aims to strengthen investor relations and showcase the company's advancements in life science technologies.

Market Sentiment Analysis

POSITIVE FACTORS

  • Participation in two major investor conferences enhances visibility.
  • Fireside Chats and one-on-one meetings provide direct engagement with investors.
  • Management's presence indicates confidence and strategic communication.

Full Press Release Details

HOLLISTON, Mass., March 12, 2025 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Jim Green, Chairman and Chief Executive Officer, and Jennifer Cote, Chief Financial Officer, will participate in two investor conferences in March 2025:
The 37th Annual Roth Conference is being held on March 16-18, 2025, at the Laguna Cliffs Marriott Resort in Dana Point, CA. On March 17th, management will host one-on-one meetings and is scheduled for a Fireside Chat on the same day starting at 10 a.m. PT (1:00 p.m. ET). The live webcast is available on HBIO’s website at https://investor.harvardbioscience.com/events-and-presentations. Investors interested in scheduling a one-on-one meeting can contact oneonone@roth.com.
The KeyBanc Capital Markets Healthcare Forum is a virtual event scheduled for March 19, 2025. Management will host one-on-one meetings and is also scheduled for a Fireside Chat with Paul Knight, KeyBanc Capital Markets, on the same day starting at 3:45 p.m. ET. The live webcast is available on HBIO’s website at https://investor.harvardbioscience.com/events-and-presentations. Investors interested in scheduling a one-on-one meeting can contact kbcmhealthcareconferenceteam@key.com.
About Harvard Bioscience, Inc.
Harvard Bioscience, Inc. is a leading developer, manufacturer and seller of technologies, products and services that enable fundamental advances in life science applications, including research, pharmaceutical and therapy discovery, bio-production and preclinical testing for pharmaceutical and therapy development. Our customers range from renowned academic institutions and government laboratories to the world’s leading pharmaceutical, biotechnology and contract research organizations. With operations in North America, Europe, and China, we sell through a combination of direct and distribution channels to customers around the world. For more information, please visit our website at www.harvardbioscience.com
Jennifer Cote, Chief Financial Officer
Sandy Martin / Erol Girgin

Frequently Asked Questions

What investor conferences will Harvard Bioscience join in March 2025?

Harvard Bioscience will participate in the 37th Annual Roth Conference and the KeyBanc Capital Markets Healthcare Forum in March 2025.

When is the Roth Conference taking place?

The Roth Conference will be held from March 16-18, 2025, in Dana Point, CA.

Where can I watch the live webcasts of the conferences?

Live webcasts can be viewed on Harvard Bioscience's website at investor.harvardbioscience.com.

How can investors schedule one-on-one meetings?

Investors can schedule one-on-one meetings by contacting oneonone@roth.com or kbcmhealthcareconferenceteam@key.com.

Who are the key executives attending the conferences?

Jim Green, CEO, and Jennifer Cote, CFO of Harvard Bioscience, will attend the conferences.

Tags: HBIO Viatris Investor Conferences Healthcare Harvard Bioscience investor conferences life science pharmaceutical
Last updated: Mar 12, 2025